Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Garfield Heights › NPI 1942248737
Hospital

Marymount Hospital INC

Marymount Hospital INC was paid $28.02M by Medicaid between Jan 2018 and Dec 2024, across 290 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 17% of everything it billed.

33Billing provider infoMARYMOUNT HOSPITAL INC
GARFIELD HEIGHTS, OH 44125
33aNPI1942248737assigned 06/03/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$28.02M
24GClaims721,869
24DCodes billed290
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#41 of 101
Median peer was paid$22.32M
This provider vs. median1.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201854,590$2.08M
201952,481$2.07M
202040,633$2.77M
202160,113$3.57M
202264,587$2.97M
2023259,388$8.88M
2024incomplete190,077$5.67M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
96361 Intravenous infusion, hydration; each additional hour 17% 16,965 13,508 $4.87M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 16% 39,183 36,081 $4.54M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 16% 41,235 38,973 $4.49M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 16% 35,132 30,875 $4.42M
70450 Computed tomography, head or brain; without contrast material 3.5% 4,081 3,415 $988K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 2.5% 6,684 5,831 $705K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.5% 4,709 4,277 $688K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.2% 2,788 2,310 $629K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.5% 2,227 1,901 $421K
G0378 Hospital observation service, per hour 1.5% 5,184 2,224 $419K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1.5% 6,375 4,729 $412K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.4% 1,983 1,116 $392K
278 more codes
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.4% 3,066 $391K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.4% 3,650 $386K
71260 Computed tomography, thorax, diagnostic; with contrast material 1.0% 1,410 $292K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,489 $272K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 593 $232K
80053 Comprehensive metabolic panel <1% 38,422 $203K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 927 $165K
93308 <1% 604 $164K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 3,142 $155K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 3,870 $142K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 625 $138K
90839 <1% 1,027 $118K
90853 Group psychotherapy (other than of a multiple-family group) <1% 1,036 $90K
82805 <1% 2,728 $87K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 985 $78K
93975 <1% 696 $78K
87631 <1% 500 $72K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 329 $69K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 111 $66K
80048 Basic metabolic panel (calcium, ionized) <1% 8,553 $62K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 4,652 $60K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 463 $55K
93971 <1% 872 $54K
70498 <1% 229 $53K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 2,006 $52K
93970 <1% 454 $49K
71046 Radiologic examination, chest; 2 views <1% 9,693 $49K
64447 <1% 230 $41K
71250 <1% 501 $39K
84484 <1% 14,423 $37K
12001 <1% 232 $35K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 36,788 $32K
76770 <1% 224 $30K
36415 Collection of venous blood by venipuncture <1% 38,305 $30K
77067 Screening mammography, bilateral, including computer-aided detection <1% 980 $30K
72131 <1% 444 $28K
86850 <1% 1,375 $28K
84443 Thyroid stimulating hormone (TSH) <1% 2,644 $27K
97161 <1% 1,078 $27K
C9290 Injection, bupivacaine liposome, 1 mg <1% 289 $26K
76830 Ultrasound, transvaginal <1% 607 $26K
70491 <1% 86 $25K
72125 Computed tomography, cervical spine; without contrast material <1% 1,654 $25K
97165 <1% 587 $25K
80061 Lipid panel <1% 2,208 $24K
81513 <1% 191 $24K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 26,508 $24K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 4,073 $21K
85027 <1% 10,471 $20K
71045 Radiologic examination, chest; single view <1% 9,646 $20K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,118 $20K
83970 <1% 1,038 $19K
83036 Hemoglobin; glycosylated (A1C) <1% 1,704 $18K
97116 <1% 967 $18K
97535 Self-care/home management training, each 15 minutes <1% 699 $17K
93799 <1% 3,368 $17K
96367 <1% 598 $16K
C1776 Joint device (implantable) <1% 46 $15K
64415 <1% 71 $15K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 20,419 $14K
86900 <1% 1,386 $14K
70486 <1% 565 $14K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 9,611 $14K
77063 Screening digital breast tomosynthesis, bilateral <1% 313 $14K
71275 Computed tomographic angiography, chest, with contrast material <1% 37 $13K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 107 $13K
72100 <1% 484 $13K
97802 <1% 268 $11K
70551 Magnetic resonance imaging, brain; without contrast material <1% 74 $11K
81001 <1% 25,411 $11K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 4,096 $11K
84702 <1% 1,579 $10K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 15 $10K
83735 <1% 18,233 $10K
82728 <1% 671 $10K
90715 <1% 642 $9K
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring <1% 28 $9K
82962 <1% 8,488 $9K
76801 <1% 574 $9K
73502 <1% 815 $9K
80069 <1% 718 $9K
86780 <1% 1,864 $9K
76857 <1% 674 $9K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 63 $9K
73030 <1% 1,103 $9K
85610 <1% 6,681 $9K
73564 <1% 886 $8K
82607 <1% 669 $8K
94060 <1% 104 $8K
A9270 Non-covered item or service <1% 1,988 $8K
64450 <1% 76 $8K
73630 <1% 1,300 $8K
86803 <1% 424 $7K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 484 $7K
99214 Doctor's office visit, returning patient (more involved) <1% 313 $7K
86140 <1% 951 $7K
84439 <1% 413 $7K
83880 <1% 2,331 $7K
76642 <1% 50 $7K
83540 <1% 921 $7K
96376 <1% 2,449 $7K
73130 <1% 902 $7K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 15 $6K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,191 $6K
88307 <1% 56 $6K
83550 <1% 912 $6K
82570 <1% 639 $5K
73610 <1% 1,038 $5K
74018 <1% 337 $5K
99215 Doctor's office visit, returning patient (complex) <1% 146 $5K
97162 <1% 122 $5K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 510 $5K
J1756 Injection, iron sucrose, 1 mg <1% 202 $5K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 3,511 $4K
96368 <1% 197 $4K
86901 <1% 1,386 $4K
87340 <1% 382 $4K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 2,539 $4K
70496 <1% 272 $4K
73560 <1% 592 $4K
73110 <1% 595 $4K
10060 <1% 26 $4K
12011 <1% 27 $4K
80076 <1% 379 $4K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 391 $4K
96375 Therapeutic injection; each additional sequential IV push <1% 6,634 $4K
82077 <1% 3,287 $3K
84153 <1% 187 $3K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 16 $3K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 2,710 $3K
82043 <1% 491 $3K
93017 <1% 44 $3K
82310 <1% 254 $3K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 15 $3K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 579 $2K
84100 <1% 881 $2K
99152 <1% 765 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 823 $2K
76536 <1% 27 $2K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 514 $2K
73090 <1% 148 $2K
82330 <1% 3,025 $2K
94729 <1% 68 $2K
83605 <1% 3,319 $2K
95012 <1% 18 $2K
87077 <1% 828 $2K
80197 <1% 103 $2K
85379 <1% 2,438 $2K
83690 <1% 6,368 $2K
73140 <1% 341 $2K
12002 <1% 14 $1K
74174 <1% 12 $1K
84132 <1% 3,918 $1K
82550 <1% 1,392 $1K
73590 <1% 290 $1K
80320 <1% 171 $1K
81025 <1% 17,492 $1K
85730 <1% 2,255 $1K
86703 <1% 1,320 $1K
85652 <1% 365 $1K
73080 <1% 190 $1K
76870 <1% 27 $1K
84450 <1% 760 $1K
82746 <1% 181 $981.33
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 25 $957.97
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,759 $918.29
77061 <1% 28 $886.28
84460 <1% 725 $859.28
85018 <1% 2,761 $796.50
87186 <1% 650 $790.87
82375 <1% 2,706 $769.70
0002A <1% 23 $721.62
84550 <1% 122 $709.45
00731 <1% 436 $706.42
99221 <1% 59 $689.08
80143 <1% 565 $679.22
77065 Tomosynthesis, mammo <1% 51 $651.60
J1170 Injection, hydromorphone, up to 4 mg <1% 711 $604.36
83050 <1% 2,683 $596.01
96127 <1% 18 $565.80
01400 <1% 307 $559.12
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,288 $535.18
J1815 Injection, insulin, per 5 units <1% 87 $512.70
82435 <1% 2,282 $481.49
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 12,210 $474.46
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 943 $471.03
90688 <1% 33 $463.00
0001A <1% 30 $419.68
84295 <1% 2,637 $398.70
J2704 Injection, propofol, 10 mg <1% 8,374 $398.21
87430 <1% 1,375 $380.22
80179 <1% 553 $371.12
J1650 Injection, enoxaparin sodium, 10 mg <1% 340 $332.98
00811 <1% 161 $325.02
00320 <1% 340 $325.02
86706 <1% 35 $313.38
J1644 Injection, heparin sodium, per 1000 units <1% 1,694 $302.16
87070 <1% 205 $290.30
87040 <1% 785 $283.09
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 453 $276.23
Q3014 Telehealth originating site facility fee <1% 13 $251.98
J3490 Unclassified drugs <1% 76 $249.43
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 41 $214.36
82553 <1% 20 $214.23
87481 <1% 39 $212.61
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 6,200 $211.46
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,299 $204.54
73552 <1% 14 $199.10
71101 <1% 52 $199.10
81003 <1% 43 $197.89
87808 <1% 676 $178.98
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,009 $160.57
99232 Hospital visit by a doctor, follow-up day <1% 14 $154.98
82565 <1% 15 $145.52
J1790 Injection, droperidol, up to 5 mg <1% 1,481 $134.86
J3010 Injection, fentanyl citrate, 0.1 mg <1% 4,016 $121.45
80164 <1% 32 $118.30
82784 <1% 15 $118.12
Q0247 Injection, sotrovimab, 500 mg <1% 22 $114.85
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 250 $106.48
82010 <1% 593 $104.03
87205 <1% 155 $101.02
72170 <1% 17 $99.54
C9113 Injection, pantoprazole sodium, per vial <1% 199 $98.90
76937 <1% 13 $96.42
J0690 Injection, cefazolin sodium, 500 mg <1% 2,201 $94.40
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,904 $92.88
J2060 Injection, lorazepam, 2 mg <1% 878 $89.43
J0780 Injection, prochlorperazine, up to 10 mg <1% 568 $80.72
77066 Tomosynthesis, mammo <1% 14 $68.49
J7030 Infusion, normal saline solution , 1000 cc <1% 1,415 $65.30
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,406 $58.35
83921 <1% 17 $56.32
82272 <1% 45 $51.88
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 613 $51.74
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 3,530 $49.45
84145 <1% 29 $47.05
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,684 $45.13
36410 <1% 14 $44.05
J3475 Injection, magnesium sulfate, per 500 mg <1% 1,066 $36.88
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 757 $24.13
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 530 $23.60
J0360 Injection, hydralazine hcl, up to 20 mg <1% 75 $23.20
J3370 Injection, vancomycin hcl, 500 mg <1% 379 $23.05
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 187 $21.99
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,071 $21.87
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 275 $21.06
J1940 Injection, furosemide, up to 20 mg <1% 124 $20.90
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 868 $20.58
80177 <1% 30 $15.77
J3480 Injection, potassium chloride, per 2 meq <1% 341 $14.56
87088 <1% 15 $8.60
J1630 Injection, haloperidol, up to 5 mg <1% 47 $6.56
J1171 Injection, hydromorphone, 0.1 mg <1% 40 $5.85
J1596 Injection, glycopyrrolate, 0.1 mg <1% 529 $5.43
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 86 $2.82
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 1,229 $1.55
91300 <1% 58 $0.33
Q0240 Injection, casirivimab and imdevimab, 600 mg <1% 29 $0.24
Q0243 Injection, casirivimab and imdevimab, 2400 mg <1% 25 $0.16
Q0244 Injection, casirivimab and imdevimab, 1200 mg <1% 14 $0.10
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 419 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 173 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 26 $0.00
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 0% 16 $0.00
01844 0% 22 $0.00
3078F 0% 74 $0.00
87899 0% 17 $0.00
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg 0% 62 $0.00
J2175 Injection, meperidine hydrochloride, per 100 mg 0% 235 $0.00
C1769 Guide wire 0% 378 $0.00
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose 0% 245 $0.00
94760 0% 1,423 $0.00
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 0% 49 $0.00
00813 0% 68 $0.00
86308 0% 27 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 25 $0.00
88304 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLARAWAY, DENNIS (EXECUTIVE VP CHIEF FINANCE OFFICER)
Same official

Other billing entities under LARAWAY, DENNIS

Full network →
ProviderLocationPaid
The Cleveland Clinic FoundationCleveland, OH$863.55M
Akron General Medical CenterAkron, OH$98.99M
Cleveland Clinic Mercy HospitalCanton, OH$86.97M
Memorial Hermann Health SystemHouston, TX$84.45M
Fairview HospitalCleveland, OH$62.42M
Lutheran HospitalCleveland, OH$41.49M
Cleveland Clinic Health System - East RegionEuclid, OH$40.67M
Memorial Hermann Health SystemHouston, TX$39.46M
Cleveland Clinic Children's Hospital for RehabilitationCleveland, OH$36.43M
Cleveland Clinic Health System - East RegionMayfield Hts, OH$32.76M
Cleveland Clinic Health System - East RegionWarrensville Heights, OH$31.44M
Partners Physician GroupAkron, OH$28.37M
Memorial Hermann Health SystemHumble, TX$26.79M
Martin Memorial Medical Center INCStuart, FL$26.03M
The Union Hospital AssociationDover, OH$20.23M
Lodi Community HospitalLodi, OH$17.53M
Clinic Medical Services Company LLCCleveland, OH$10.82M
Cleveland Clinic Home Care ServicesIndependence, OH$10.76M
Indian River Memorial Hospital INCVero Beach, FL$9.27M
Memorial Hermann Health SystemSugar Land, TX$9.14M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.